Company Filing History:
Years Active: 2018
Title: Calman Alexander MacLennan: Innovator in Vaccine Development
Introduction
Calman Alexander MacLennan is a notable inventor based in Siena, Italy. He has made significant contributions to the field of vaccine development, particularly in the area of Salmonella conjugate vaccines. His work is essential in advancing public health and combating infectious diseases.
Latest Patents
Calman holds a patent for Salmonella conjugate vaccines. This invention relates to a conjugate based on Vi polysaccharide, which is fragmented and combined with a carrier protein. The patent also covers compositions comprising this conjugate and methods for making these conjugates and compositions. His innovative approach has the potential to enhance vaccine efficacy and safety.
Career Highlights
Calman is currently associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical industry. His role at the company allows him to work on groundbreaking research and development projects that aim to improve global health outcomes.
Collaborations
Throughout his career, Calman has collaborated with esteemed colleagues, including Laura Bartle Martin and Francesca Micoli. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Calman Alexander MacLennan is a distinguished inventor whose work in vaccine development is making a significant impact on public health. His contributions, particularly in the area of Salmonella conjugate vaccines, highlight the importance of innovation in combating infectious diseases.